Account
Maxus wins media mandate for ICC World Twenty20 Bangladesh 2014
MUMBAI: Maxus has bagged the media investment mandate in India for the ICC World Twenty20 Bangladesh 2014. The media agency had previously handled three campaigns in India for the International Cricket Council (ICC), including the ICC Cricket World Cup 2011, ICC World Twenty20 Sri Lanka 2012 and ICC Champions Trophy England & Wales 2013.
The ICC World Twenty20 Bangladesh 2014 started on 16 March and will conclude in Mirpur on 6 April, during which a total of 60 tournament matches (35 men’s and 25 women’s) will be played across Chittagong, Mirpur and Sylhet.
“Cricket captures the hearts and minds of our nation, and Maxus is extremely proud and excited to manage the media duties for the ICC World Twenty20 Bangladesh 2014. The T20 format has taken the game to a whole new audience, especially women and kids, and there still lies a huge opportunity to make the game bigger!” said Maxus managing director Kartik Sharma.
The format of the men’s event this year has seen a change following an increase in teams from 12 to 16. As the teams’ seedlings are based on the Reliance ICC T20 Team Rankings as on 8 October 2012, the top eight sides following the conclusion of the ICC World Twenty20 Sri Lanka 2012 will play directly in the Super 10 stage. Bangladesh and Zimbabwe, which finished outside the top eight, are currently participating in the first round of the tournament in Chittagong and Sylhet. Top two sides from each group will progress to the Super 10 Stage which will kick-off in Mirpur with the match between former champions and traditional rivals India and Pakistan.
The women’s event will take place in Sylhet from 23 March with the semi-finals and final to be played ahead of the men’s matches in Mirpur. Australia will aim to complete a hat-trick of titles in the tournament. The number of teams for this tournament has been increased from eight to 10 and they have been equally divided into two groups with the top two sides progressing to the semi-finals.
Recently Maxus India was ranked as the ‘Most Dominant Agency in India’ for the fourth year in a row, as per the latest RECMA ratings, topping the list across Indian agencies.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
